CD40 Cross-Linking Induces Migration of Renal Tumor Cell through Nuclear Factor of Activated T Cells (NFAT) Activation

Abstract

CD40 crosslinking plays an important role in regulating cell migration, adhesion and proliferation in renal cell carcinoma (RCC). CD40/CD40L interaction on RCC cells activates different intracellular pathways but the molecular mechanisms leading to cell scattering are not yet clearly defined. Aim of our study was to investigate the main intracellular pathways activated by CD40 ligation and their specific involvement in RCC cell migration. CD40 ligation increased the phosphorylation of extracellular signal-regulated kinase (ERK), c-Jun NH (2)-terminal kinase (JNK) and p38 MAPK. Furthermore, CD40 crosslinking activated different transcriptional factors on RCC cell lines: AP-1, NFkB and some members of the Nuclear Factor of Activated T cells (NFAT) family. Interestingly, the specific inhibition of NFAT factors by cyclosporine A, completely blocked RCC cell motility induced by CD40 ligation. In tumor tissue, we observed a higher expression of NFAT factors and in particular an increased activation and nuclear migration of NFATc4 on RCC tumor tissues belonging to patients that developed metastases when compared to those who did not. Moreover, CD40-CD40L interaction induced a cytoskeleton reorganization and increased the expression of integrin β1 on RCC cell lines, and this effect was reversed by cyclosporine A and NFAT inhibition. These data suggest that CD40 ligation induces the activation of different intracellular signaling pathways, in particular the NFATs factors, that could represent a potential therapeutic target in the setting of patients with metastatic RCC.

Role of Complement in Regulating Inflammation Processes in Renal and Prostate Cancers

“…Moreover, PTX3 promotes cellular proliferation, confers resistance to apoptosis by altering cell cycle signalling, thereby promoting cancer cell invasion and migration, and tumour escape from immunosurveillance [57,[66][67][68]. It facilitates dysregulation of mitogenic signalling pathways, sustains cellular proliferation, angiogenesis, insensitivity to apoptosis, cancer cell invasion and migration, and tumor escape from immunosurveillance.…”

Co-stimulators CD40-CD40L, a potential immune-therapy target for atherosclerosis: A review

“…[31] In addition to TRAF and the Src family, CD40 signal transduction is intricately linked to the mitogen-activated protein kinase (MAPK), NF-κB, and nuclear factor of activated T cells pathways. [32,33] The MAPK family, comprising 3 primary members-ERK, JNK, and p38 MAPK, plays a vital role in the signaling transduction processes across various cell types. These kinases can mediate a range of biological effects, including cellular growth, proliferation, cytokine secretion, survival, and programmed cell death by activating transcription factors.…”